SAN FRANCISCO (Thomson Financial) - Accipiter Life Sciences Fund LP late
Friday said it has nominated a slate of three independent directors for election
to the board of Penwest Pharmaceuticals Co. at the company's annual meeting.
The nominees are Gabe Hoffman, David Lohman and Eugene Davis, Accipiter
said.
Together with its affiliates, Accipiter beneficially owns 2.17 million
shares, or a 9.3% stake in Penwest.
Shares of Danbury, Conn.-based Penwest, a developer of pharmaceutical
products, closed the regular session down 20 cents, or about 5%, at $3.71.
Katherine Hunt
kh
COPYRIGHT
Copyright Thomson Financial News Limited 2007. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content,
including by framing or similar means, is expressly prohibited without the prior
written consent of Thomson Financial News.
|